Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $249.91M.
ENTERPRISE VALUE (EV)
$249.91M
C4 Therapeutics, Inc.
Market Cap
$324.51M
Enterprise Value (EV)
$249.91M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | $324.51M | $249.91M |
| Cabaletta Bio, Inc. (CABA)vs › | $325.29M | $125.91M |
| CapsoVision, Inc. (CV)vs › | $319.08M | $310.69M |
| ClearPoint Neuro, Inc. (CLPT)vs › | $333.12M | $367.70M |
| Agenus Inc. (AGEN)vs › | $336.05M | $358.02M |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $307.55M | $138.89M |
| Benitec Biopharma Inc. (BNTC)vs › | $302.66M | $123.45M |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $346.77M | $55.17M |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $352.79M | $375.03M |
| Opus Genetics, Inc. (IRD)vs › | $354.20M | $300.32M |
Market Cap
$324.51M
Total Debt
$0.00
Cash
$74.60M
Enterprise Value
$249.91M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
